Literature DB >> 17975026

Successful application of a direct detection slide-based sequential phenotype/genotype assay using archived bone marrow smears and paraffin embedded tissue sections.

Victoria Bedell1, Stephen J Forman, Karl Gaal, Vinod Pullarkat, Lawrence M Weiss, Marilyn L Slovak.   

Abstract

Identification of genetic abnormalities in pathological samples is critical for accurate diagnosis, risk stratification, detection of minimal residual disease, and assessment of response to therapy. Interphase fluorescence in situ hybridization analysis is the standard cytogenetic assay used by many laboratories to detect specific clonal karyotypic aberrations in formalin-fixed, paraffin-embedded tissue. However, direct correlation with immunophenotype or morphology in individual cells is rarely performed because the procedural steps are labor intensive and usually require extensive troubleshooting. In this study, we present a sequential fluorescence in situ hybridization-based technique that uses the identical archived bone marrow smears or paraffin-embedded tissue sections previously evaluated by a pathologist for morphological or immunohistochemical characteristics. This approach is relatively straightforward, using uncomplicated pretreatment and hybridization conditions and basic equipment attached to an automated image analyzer with image capture software to record the location of targeted cells for genotypic/phenotype correlation. Furthermore, the method has proved reliable and reproducible on test samples regardless of specimen age, tissue type, or referring institution.

Entities:  

Mesh:

Year:  2007        PMID: 17975026      PMCID: PMC2049056          DOI: 10.2353/jmoldx.2007.070050

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  36 in total

1.  Occurrence of additional chromosome aberrations in chronic myeloid leukemia patients treated with imatinib mesylate.

Authors:  C Schoch; T Haferlach; W Kern; S Schnittger; U Berger; R Hehlmann; W Hiddemann; A Hochhaus
Journal:  Leukemia       Date:  2003-02       Impact factor: 11.528

2.  Neoplastic mast cells in systemic mastocytosis associated with t(8;21) acute myeloid leukemia are derived from the leukemic clone.

Authors:  Vinod Pullarkat; Victoria Bedell; Young Kim; Ravi Bhatia; Ryotaro Nakamura; Stephen Forman; Jiyao Sun; David Senitzer; Marilyn L Slovak
Journal:  Leuk Res       Date:  2006-07-28       Impact factor: 3.156

3.  Immunoglobulin heavy chain gene analysis in lymphomas: a multi-center study demonstrating the heterogeneity of performance of polymerase chain reaction assays.

Authors:  Adam Bagg; Rita M Braziel; Daniel A Arber; Karen E Bijwaard; Albert Y Chu
Journal:  J Mol Diagn       Date:  2002-05       Impact factor: 5.568

4.  Feasibility of simultaneous fluorescence immunophenotyping and fluorescence in situ hybridization study for the detection of estrogen receptor expression and deletions of the estrogen receptor gene in breast carcinoma cell lines.

Authors:  Y Zhang; R Siebert; P Matthiesen; S Harder; M Theile; S Scherneck; B Schlegelberger
Journal:  Virchows Arch       Date:  2000-03       Impact factor: 4.064

5.  Cytogenetics and age are major determinants of outcome in intensively treated acute myeloid leukemia patients older than 60 years: results from AMLSG trial AML HD98-B.

Authors:  Stefan Fröhling; Richard F Schlenk; Sabine Kayser; Martina Morhardt; Axel Benner; Konstanze Döhner; Hartmut Döhner
Journal:  Blood       Date:  2006-07-13       Impact factor: 22.113

6.  Multicolor-FICTION: expanding the possibilities of combined morphologic, immunophenotypic, and genetic single cell analyses.

Authors:  José Ignacio Martín-Subero; Ilse Chudoba; Lana Harder; Stefan Gesk; Werner Grote; Francisco Javier Novo; María José Calasanz; Reiner Siebert
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

7.  Demonstration of Philadelphia chromosome negative abnormal clones in patients with chronic myelogenous leukemia during major cytogenetic responses induced by imatinib mesylate.

Authors:  M E O'Dwyer; K M Gatter; M Loriaux; B J Druker; S B Olson; R E Magenis; H Lawce; M J Mauro; R T Maziarz; R M Braziel
Journal:  Leukemia       Date:  2003-03       Impact factor: 11.528

8.  Chimerism testing and detection of minimal residual disease after allogeneic hematopoietic transplantation using the bioView (Duet) combined morphological and cytogenetical analysis.

Authors:  A Shimoni; A Nagler; C Kaplinsky; M Reichart; A Avigdor; I Hardan; M Yeshurun; M Daniely; Y Zilberstein; N Amariglio; F Brok-Simoni; G Rechavi; L Trakhtenbrot
Journal:  Leukemia       Date:  2002-08       Impact factor: 11.528

9.  Determination of chromosome 13 status in bone marrow cells of patients with multiple myeloma using combined morphologic and fluorescence in situ hybridization analysis.

Authors:  Izhar Hardan; Rachel Rothman; Alain Gelibter; Ninette Cohen; Avichai Shimoni; Maya Sokolovsky; Malka Reichart; Galina Ishoev; Ninette Amariglio; Gideon Rechavi; Arnon Nagler; Luba Trakhtenbrot
Journal:  Exp Hematol       Date:  2004-03       Impact factor: 3.084

10.  A new method to extract nuclei from paraffin-embedded tissue to study lymphomas using interphase fluorescence in situ hybridization.

Authors:  Sarah F Paternoster; Stephanie R Brockman; Rebecca F McClure; Ellen D Remstein; Paul J Kurtin; Gordon W Dewald
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

View more
  5 in total

1.  Molecular karyotypes of Hodgkin and Reed-Sternberg cells at disease onset reveal distinct copy number alterations in chemosensitive versus refractory Hodgkin lymphoma.

Authors:  Marilyn L Slovak; Victoria Bedell; Ya-Hsuan Hsu; Dolores B Estrine; Norma J Nowak; Maria L Delioukina; Lawrence M Weiss; David D Smith; Stephen J Forman
Journal:  Clin Cancer Res       Date:  2011-03-08       Impact factor: 12.531

2.  Molecular characteristics of diffuse large B-cell lymphoma in human immunodeficiency virus-infected and -uninfected patients in the pre-highly active antiretroviral therapy and pre-rituximab era.

Authors:  Lindsay M Morton; Clara J Kim; Lawrence M Weiss; Kishor Bhatia; Myles Cockburn; Debra Hawes; Sophia S Wang; Cindy Chang; Sean F Altekruse; Eric A Engels; Wendy Cozen
Journal:  Leuk Lymphoma       Date:  2013-07-29

3.  Neural Stem Cell-Based Anticancer Gene Therapy: A First-in-Human Study in Recurrent High-Grade Glioma Patients.

Authors:  Jana Portnow; Timothy W Synold; Behnam Badie; Revathiswari Tirughana; Simon F Lacey; Massimo D'Apuzzo; Marianne Z Metz; Joseph Najbauer; Victoria Bedell; Tien Vo; Margarita Gutova; Paul Frankel; Mike Chen; Karen S Aboody
Journal:  Clin Cancer Res       Date:  2016-12-15       Impact factor: 12.531

4.  A Preliminary Study of the Suitability of Archival Bone Marrow and Peripheral Blood Smears for Diagnosis of CML Using FISH.

Authors:  Alice Charwudzi; Edeghonghon E Olayemi; Ivy Ekem; Olufunmilayo Olopade; Mariann Coyle; Amma Anima Benneh; Emmanuel Alote Allotey
Journal:  Adv Hematol       Date:  2014-09-22

5.  Association Between Spatial Heterogeneity Within Nonmetastatic Gastroesophageal Adenocarcinomas and Survival.

Authors:  Joseph Chao; Victoria Bedell; Jeeyun Lee; Min Sierra Li; Peiguo Chu; Yate-Ching Yuan; Dan Zhao; Samuel J Klempner; Ren-Jang Lin
Journal:  JAMA Netw Open       Date:  2020-04-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.